Hematological Diseases and Apoptosis
スポンサーリンク
概要
- 論文の詳細を見る
- Japanese Society of Internal Medicineの論文
- 1998-02-01
著者
-
KAWABATA HIROSHI
Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University
-
TOHYAMA Kaoru
Department of Laboratory Medicine, Kawasaki Medical School
-
HISHITA Terutoshi
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University
-
Yoshida Yataro
Center For Southeast Asian Studies Kyoto University
-
ANZAI Naoyuki
Division of Hematology/Oncology, Graduate School of Medicine, Kyoto University
-
HISHITA Terutoshi
Division of Hematology/Oncology, Graduate School of Medicine, Kyoto University
-
DODO Mayumi
Division of Hematology/Oncology, Graduate School of Medicine, Kyoto University
-
Dodo Mayumi
Division Of Hematology/oncology Graduate School Of Medicine Kyoto University
-
Anzai Naoyuki
Division Of Hematology/oncology Graduate School Of Medicine Kyoto University
-
Kawabata Hiroshi
Division Of Hematology/oncology Graduate School Of Medicine Kyoto University
-
Tohyama K
Department Of Laboratory Medicine Kawasaki Medical School
-
Tohyama Kaoru
Department Of Laboratory Medicine
-
Hishita T
National Hospital Organization Hyogo Jpn
-
Yoshida Yataro
Center For South Ease Asian Studies Kyoto University
-
HISHITA Terutoshi
Division of Hematology and Immunology, Department of Internal Medicine, Ohtsu Red Cross Hospital
関連論文
- Occurrence of Multiple Ethyl 4-Chloro-3-Oxobutanoate-Reducing Enzymes in Candida magnoliae
- Purification and Characterization of NADPH-Dependent Carbonyl Reductase, Involved in Stereoselective Reduction of Ethyl 4-Chloro-3-oxobutanoate, from Candida magnoliae
- Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality
- A Prospective Study of Cyclosporine A Treatment of Patients with Low-Risk Myelodysplastic Syndrome : Presence of CD55^-CD59^- Blood Cells Predicts Platelet Response
- Effects of the Tyrosine Kinase Inhibitor Imatinib Mesylate on a Bcr-Abl-Positive Cell Line : Suppression of Autonomous Cell Growth but No Effect on Decreased Adhesive Property and Morphological Changes
- Vacuolar H^+-ATPase Inhibitor Induces Apoptosis via Lysosomal Dysfunction in the Human Gastric Cancer Cell Line MKN-1
- Diagnostic and biological significance of sideroblastic erythropoiesis in the myelodysplastic syndromes
- Prevalence of the myelodysplastic syndromes in Japan
- Epstein-Barr Virus-Associated Anaplastic Large Cell Variant of Diffuse Large B-Cell-Type Non-Hodgkin's Lymphoma with Concurrent p53 Protein Expression
- Epstein-Barr Virus-Associated B-Cell Type Non-Hodgkin's Lymphoma with Concurrent p53 Protein Expression in a Rheumatoid Arthritis Patient Treated with Methotrexate
- Hematological Diseases and Apoptosis
- Distribution of endogenous endonuclease activities capable of producing internucleosomal DNA cleavage in hematopoietic cells
- Transformation from follicular lymphoma to high-grade B-cell lymphoma/leukemia with additional t(2;8)(p12;q24), with inverse expressions of c-MYC and BCL-2, and light-chain switch
- Immunophenotypic Analysis of Various Blastic Crises in Chronic Myeloid Leukemia : Correlations between CD7 Expression and Response to Chemotherapy
- Reversible Acceleration of Disease Progression Following Cyclosporin A Treatment in a Patient With Myelodysplastic Syndrome
- The impact of serum soluble interleukin-2 receptor levels on the diagnosis of malignant lymphoma
- Human factor-dependent leukemia cell lines
- Erythropoietin Therapy for Aplastic Anemia
- Clinical utility of the neutrophil distribution pattern obtained using the CELL-DYN SAPPHIRE hematology analyzer for the diagnosis of myelodysplastic syndrome
- 5q-syndrome in Japan
- Persistent thrombocytosis in elderly patients with rare hyposplenias that mimic essential thrombocythemia
- Direct Ab-initio Molecular Dinamics Study on the Diffusion of Alkali Ions on Amorphous Carbon
- Leukemic and Meningeal Relapse of CD5^+ Intravascular Large B-Cell Lymphoma with Down-Modulation of CD20 after Rituximab Therapy